Experience

Download Dawn Little's resume (80KB PDF)

Senior Executive, Business Strategy

Twenty+ years' combined executive, internal consulting, international, and audit leadership experience in Fortune companies and the Big Four, including Purdue Pharma, Becton Dickinson & Company, PricewaterhouseCoopers, and IBM. Background as CPA. MBA in Accounting.

Value & ROI

Prevented imminent closure of plant generating 80% of net revenue. Worked 80+ straight days to develop emergency plans that helped meet $400+ million Q4 sales target and satisfy government, company executives, and stakeholders.

Reengineered finance analytics infrastructure. Introduced first-ever metrics / reporting systems to meet challenges of accelerated growth ($300 million annual sales to $2+ billion in 5 years).

Led $2 million system conversion project, and increased payroll team efficiency by 30% through difficult turn-around, concurrently identifying and mitigating control weaknesses.

Chronology

Passaic County Community College, Paterson, NJ
2006 to Present

Adjunct Professor of Accounting


Purdue Pharma L.P. (& independent associated companies), Stamford, CT
1996 to 2004

Privately held, $2+ billion net sales, global consumer pharmaceutical conglomerate. IAF Corporation and P.F. Laboratories are Purdue independent business alliances providing strategic oversight and manufacturing.


Senior Manager (IAF Corporation)
2004
Senior Manager, Operations (P. F. Laboratories)
2002 to 2003
Manager, Financial & Systems Analysis (Purdue Pharma)
1998 to 2002
Audit Manager / Senior Auditor / Auditor (IAF Corporation)
1996 to 1998


Accountability

Budgets: to $2 million
Reported: Sr. EVP / International Legal Counsel and Board of Directors with dotted line to CFO
Managed: 3 to 4 direct reports; teams of 20 indirectly
Locations: US, Canada, Europe, India, Cyprus, and Bermuda
Focus: Compliance, Risk Management, Corporate Governance, Internal Consultation, Project Management

Mission-Critical Impact
Recruited internally by VP/CFO to strategize pivotal rescue of factory manufacturing product equaling 80% of revenue stream.

Purdue urgently needed oversight approvals to continue making product at uninterrupted pace to meet current and future revenue goals. As OxyContin® / MS Contin® sales soared 800% from ~ $300 million / 1995 to $2.4 billion / 2003, deep infrastructure, manufacturing, FDA / DEA, and legal exposures became evident. Unannounced inspection revealed crucial non-compliance issues that threatened business continuity.

Immediately assigned by CFO and others in core management areas to lead crisis team and lay out tactical and operational strategies to prevent pending plant closure and allow ongoing manufacturing. "… The logical choice first and foremost… positive relationships with the folks at the factory… hands-on experience in operations, finance / audit expertise… in-depth knowledge of the company's products, especially controlled substances…" Controller, P.F. Labs

Strategic Business & Finance Impact
Pioneered — and volunteered to lead — the improvement, invention, and support of revenue-critical manufacturing / business processes.

Ensured 1) functioning of all systems to safeguard uninterrupted supply of controlled substance raw material for production, and 2) meeting internal and mandated external policies. Delivered added value by identifying and implementing strategic cost savings initiatives, functional / procedural re-engineering opportunities, and process improvements.

Spurred alleviation of continuous on-site inspections, and provided documentation for later civil litigation through conceiving / executing compliance counter measures. Authored position papers, created $30 million expenditures matrix, and action-planned contributions to company's "88 opportunity points."

Conducted financial / systems analyses, support, and execution, provided insightful analysis and commentary to drive future company growth and support new product development teams. Assisted in providing / developing annual company budget, semi-annual forecasts, long-range forecast statements, due diligence analyses, cost/benefit presentations, and ad hoc reports.

Becton Dickinson & Company (worldwide headquarters), Franklin Lakes, NJ
1989 to 1995

Publicly held $4.9 billion global medical technology company (25,000 employees / 50 countries). BDOSL was separate tax / legal entity supporting expatriates in 10 countries ($3+ million P&L impact; 3 payroll systems).


Expatriate Technical Specialist (BDOSL)
1994 to 1995
Special Projects Audit Manager
1992 to 1993
Audit Manager / Auditor
1989 to 1992


Accountability

Assumed project management responsibility for re-engineering corporate payroll and other finance areas. Managed daily payroll operations, auditing, and reporting for $80+ million payroll in 17 semi-monthly payroll groups. Oversaw staff of nine.

Strategic Business & Finance Impact

PricewaterhouseCoopers LLP (Formerly Price Waterhouse), New York, NY
1987 to 1989

Senior Auditor / Auditor
 
IBM (World Trade Headquarters – Europe / Middle East / Africa Division),
White Plains, NY
1986 to 1987

Paraprofessional Accountant (concurrent with full-time grad school studies)
 
 

Portfolio site by Brandego